DF PHARMA SERVICES is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €217k and a net result of €199k. Equity is growing by ~7.7% per year across the filed fiscal years. Its solvency ranks better than 14% of 5498 sector peers (fiscal year 2025). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 5498 sector peers (2025).
NBB · sector comparisonPosition among 5498 sector peers
Solvency
better than 14%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
12 d late
2024
43 d early
2023
23 d late
2022
25 d late
2021
3 d early
2020
12 d late
2019
60 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€217k▼ 87.5%
2024 · €1.74M
2018: €962k
2019: €1.11M
2020: €1.30M
2021: €1.48M
2022: €1.53M
2023: €1.52M
2024: €1.74M
2018 → 2025
Net result
€199k▼ 19.8%
2024 · €248k
2018: €402k
2019: €149k
2020: €186k
2021: €176k
2022: €165k
2023: €285k
2024: €248k
2018 → 2025
Total assets
€1.96M▼ 6.4%
2024 · €2.09M
2018: €1.52M
2019: €1.57M
2020: €1.63M
2021: €2.07M
2022: €2.02M
2023: €2.17M
2024: €2.09M
2018 → 2025
Solvency
11.1%▼ 71.9pp
2024 · 83.0%
2018: 63.2%
2019: 70.8%
2020: 79.8%
2021: 71.5%
2022: 75.6%
2023: 70.4%
2024: 83.0%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.48M-€1.53M▲ 3.2%€1.52M▼ 0.1%€1.74M▲ 13.9%€217k▼ 87.5%
Operating result€236k-€228k▼ 3.2%€376k▲ 64.9%€331k▼ 12.1%€-29k
Net result€176k-€165k▼ 6.1%€285k▲ 72.5%€248k▼ 12.9%€199k▼ 19.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €29k after €331k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.96M
Fixed assets
€491k▼ 67.1%
Current assets
€1.47M▲ 145%
Equity and liabilities €1.96M
Equity
€217k▼ 87.5%
Debt
€1.74M▲ 391%
The debt ratio rises from 17.0% to 88.9%. Equity is lower and debt is higher.
Key figures and ratios
Solvency
11.1%▼
2024 · 83.0%
ROE
91.4%▲
2024 · 14.3%
ROA
10.2%▼
2024 · 11.9%
Debt
€1.74M▲
2024 · €354k
Debt ≤ 1 year
€1.51M▲
2024 · €88k
Debt > 1 year
€230k▼
2024 · €261k
Income taxes
€370▼
2024 · €77k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.09M€1.96M▼
Fixed assets21/28€1.49M€491k▼
Tangible fixed assets22/27€2k€987▼
Plant, machinery and equipment23€645€273▼
Furniture and vehicles24€960€714▼
Financial fixed assets28€1.49M€490k▼
Current assets29/58€599k€1.47M▲
Amounts receivable after more than one year29-€100k
Other amounts receivable291-€100k
Amounts receivable within one year40/41€515k€102k▼
Trade receivables40€648€29k▲
Other amounts receivable41€515k€73k▼
Current investments50/53€56k€56k▲
Cash at bank and in hand54/58€24k€1.20M▲
Deferred charges and accrued income490/1€4k€6k▲
Equity and liabilities
Total equity and liabilities10/49€2.09M€1.96M▼
Equity10/15€1.74M€217k▼
Contributions10/11€19k€19k=
Reserves13€1.72M€199k▼
Distributable reserves133€1.72M€199k▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€354k€1.74M▲
Amounts payable after more than one year17€261k€230k▼
Financial debts170/4€261k€230k▼
Amounts payable within one year42/48€88k€1.51M▲
Current portion of amounts payable after more than one year42€31k€32k▲
Financial debts43€9k€10k▲
Credit institutions430/8€9k€10k▲
Trade debts44€1k€161▼
Suppliers440/4€1k€161▼
Taxes, remuneration and social security45€16k€3k▼
Taxes450/3€16k€3k▼
Other amounts payable47/48€31k€1.46M▲
Accrued charges and deferred income492/3€5k€5k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€937€619▼
Other operating charges640/8€1k€2k▲
Gross operating margin9900€333k€-27k▼
Operating profit (loss)9901€331k€-29k▼
Financial income75/76B€231€234k▲
Recurring financial income75€231€34k▲
Non-recurring financial income76B-€200k
Financial charges65/66B€6k€5k▼
Recurring financial charges65€6k€5k▼
Profit (loss) for the period before taxes9903€325k€199k▼
Income taxes67/77€77k€370▼
Profit (loss) for the period9904€248k€199k▼
Profit (loss) for the period to be appropriated9905€248k€199k▼
Appropriation of the result
Profit (loss) to be appropriated9906€248k€199k▼
Transfer from equity791/2€0€1.72M▲
Transfer to equity691/2€212k€199k▼
To other reserves6921€212k€199k▼
Profit to be distributed694/7€36k€1.72M▲
Return on contributions (dividend)694€36k€1.72M▲
Social balance
Average headcount (FTE)90870.00.0=
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 12 days late
2025
18-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity triplescurrent ratio 6.78
Current ratio from 1.97 to 6.78; short-term debt falls from €341k to €88k.
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 23 days late
2023
25-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 25 days late
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
12-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 12 days late
2020
29-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 60 days late
2019
31-12
Financial
Weakest financial yearnet €149k ▼62.9%
Net result drops to €149k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €1MEq €1.11M ▲15.5%
2 profitable years in a row build equity to €1.11M.
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
05-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
30-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oudsbergen · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Krokusstraat 23670 OudsbergenGround area
1,607 m²
Building footprint
196 m²
Volume, LiDAR
1,244 m³
Parcel 72022B0771/00G000, Flanders · tallest building 10.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DF PHARMA SERVICES
since 20132.220.462.236
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72022B0771/00G000 | Flanders | 1,607 m² | 1 · 196 m² | 10.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CINNIC
BE 0800.531.793
Sint-Martens-Latem · Eq €217k
LDM
BE 0803.961.140
Zemst · Eq €217k
Stebofisc
BE 0474.396.316
Mol · Eq €218k
BVL Technics
BE 0795.168.386
Heist-op-den-Berg · Eq €217k
VALUE
BE 0871.537.476
Hasselt · Eq €217k
Of 24,726 companies in sector 64210 we hold annual accounts for 19,747. 13,543 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-07-2013
Fiscal year end31-12
Activities, NACEBEL
64200Holdings
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.